Postural Orthostatic Tachycardia Syndrome (POTS) Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceIncreases blood volume - critical for POTS management; salt loading is first-line treatment
Deficiency common in POTS and associated with symptom severity; supports muscle function
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsIron deficiency common in POTS and may worsen symptoms; supports blood volume
Supporting Studies (1)
Deficiency can cause or worsen autonomic dysfunction; supports nerve function
Supporting Studies (1)
Supports cardiovascular and nervous system function; may help with palpitations and muscle cramps
Supporting Studies (1)
Supports mitochondrial function; may help with fatigue common in POTS
Supporting Studies (1)
Supports cardiovascular health and may help with inflammation
Supporting Studies (1)
Important electrolyte; levels can be affected by high sodium intake
Supporting Studies (1)
Supports energy production; may help with fatigue
Supporting Studies (1)
How This Protocol Works
Simple Explanation
POTS (Postural Orthostatic Tachycardia Syndrome) is a form of dysautonomia where the autonomic nervous system doesn't properly regulate heart rate and blood vessel tone when standing. Upon standing, heart rate increases excessively (30+ bpm, or >120 bpm within 10 minutes) while blood pressure is maintained. This causes symptoms like lightheadedness, palpitations, exercise intolerance, fatigue, brain fog, nausea, and fainting. POTS often affects young women and can be triggered by viral infections (including COVID-19), pregnancy, surgery, or trauma.
CRITICAL: POTS requires diagnosis and management by a cardiologist or autonomic specialist. Diagnosis involves tilt table testing or active standing test. Treatment is multimodal: lifestyle measures (fluid/salt loading, compression garments, exercise reconditioning) are foundational, with medications (fludrocortisone, midodrine, beta-blockers, ivabradine, pyridostigmine) added as needed. Underlying causes (autoimmune, small fiber neuropathy, mast cell activation, EDS) should be investigated. These supplements support the foundational salt/fluid strategy and address common deficiencies but are NOT replacements for comprehensive medical management.
* Electrolytes/Sodium - Salt and fluid loading is the cornerstone of POTS management. Increasing salt intake to 3-10g daily (with 2-3L of fluids) helps expand blood volume and reduce symptoms. Salt tablets or electrolyte drinks are commonly used.
* Vitamin D deficiency is very common in POTS patients and may affect symptom severity.
* Iron deficiency is common and can worsen symptoms. Target ferritin levels >50-70 ng/mL.
* Vitamin B12 deficiency can cause autonomic neuropathy and should be corrected.
* Magnesium supports cardiovascular function and may help with palpitations.
* Coenzyme Q10 may help with the profound fatigue common in POTS.
* Omega-3 Fatty Acids support cardiovascular health.
* Potassium is important when increasing sodium intake significantly.
Expected timeline: Salt/fluid loading can provide relief within days. Exercise reconditioning takes 3-6 months to show significant benefits. Many patients improve over 1-5 years, though symptoms may wax and wane.
Clinical Perspective
POTS: syndrome of orthostatic intolerance with heart rate increase ≥30 bpm (≥40 in adolescents) within 10 minutes of standing, or HR >120 bpm, without orthostatic hypotension, with symptoms. Subtypes: neuropathic (partial denervation), hyperadrenergic (elevated norepinephrine), hypovolemic, mast cell activation associated. Prevalence: ~500,000-3 million US. Demographics: 80% female, typical onset 15-50 years. Triggers: viral illness (including COVID-19/long COVID), surgery, trauma, pregnancy.
CRITICAL: Diagnosis: tilt table test or active standing test (HR response + symptom reproduction); rule out other causes (anemia, thyroid, cardiac, dehydration). First-line: non-pharmacological - salt 3-10g/day + fluid 2-3L/day, compression garments (30-40 mmHg), graded exercise reconditioning (recumbent initially). Second-line: medications per phenotype - fludrocortisone (volume expansion), midodrine (vasoconstriction), low-dose propranolol (HR control), ivabradine (HR without BP effect), pyridostigmine (acetylcholinesterase inhibitor). Evaluate for: small fiber neuropathy, mast cell activation, autoimmune markers, EDS/hypermobility.
* Electrolytes/Sodium (A-grade): Blood volume expansion. Systematic review: salt/fluid (PMID: 24763732). Review: non-pharmacological treatment (PMID: 26423434). 3-10g sodium + 2-3L fluid daily.
* Vitamin D (B-grade): Common deficiency; muscle function. Study: POTS deficiency (PMID: 29784922). 2000-4000 IU daily.
* Iron (B-grade): Deficiency common. Study: POTS association (PMID: 31076291). Target ferritin >50-70.
* Vitamin B12 (C-grade): Autonomic nerve support. Review: autonomic neuropathy (PMID: 20660778). 1000-2500mcg daily if low.
* Magnesium (C-grade): Cardiovascular support. Review: (PMID: 28150472). 300-400mg daily.
* CoQ10 (C-grade): Mitochondrial support; fatigue. Systematic review: chronic fatigue (PMID: 25561212). 100-200mg daily.
* Omega-3 Fatty Acids (C-grade): Cardiovascular support. Study: autonomic function (PMID: 23597877). 1-2g daily.
* Potassium (C-grade): Electrolyte balance. Review: POTS (PMID: 25071161). Dietary or as needed.
* L-Carnitine (D-grade): Energy production. Review: fatigue (PMID: 18484901). 1-2g daily.
Assessment targets: Heart rate response to standing, symptom frequency/severity, orthostatic vital signs, fatigue scales, quality of life measures.
Protocol notes: Exercise: critical - Levine protocol (recumbent exercise, gradual progression); deconditioning worsens POTS. Salt: salt tablets (1g each, 2-3 TID), salty foods, electrolyte drinks (LMNT, Liquid IV, Nuun); avoid low-sodium diets. Fluid: water alone not sufficient - need electrolytes; IV saline temporarily helpful for severe flares. Compression: waist-high preferred over knee-high; abdominal binder helpful. Avoid: prolonged standing, alcohol, heat, large meals (blood pooling). Sleep: elevate head of bed 4-6 inches. Cooling: body temperature rises can worsen symptoms; cooling vests help. Small frequent meals: prevent postprandial hypotension. Caffeine: can help some patients (vasoconstriction) but worsen others (tachycardia). Gluten/diet: some patients report benefit from elimination diets - try if interested. Mast cell activation: common overlap; consider if flushing, GI symptoms, medication sensitivities. EDS: hypermobility common in POTS; affects management. Long COVID: significant cause of new POTS; similar treatment approach. Mental health: anxiety/depression common (from chronic illness, not cause); address supportively. Disability: many patients cannot work during severe phases; validate this.